Recurrence rates in breast cancer patients with false-negative intraoperative evaluation of sentinel lymph nodes

American Journal of Surgery

Volumn 199, Issue 5, 2010, Pages 625-628

  Taras, Angie R ^a   Hendrickson, Nyle A ^a   Lowe, Kimberly A ^b   Atwood, Mary ^a   Beatty, J David ^a  

^a SWEDISH MEDICAL CENTER   (United States)

^b Exponenta Inc   (United States)

Author keywords

Breast cancer; False negative; Intraoperative evaluation; Sentinel node

Indexed keywords

ANTINEOPLASTIC AGENT; EOSIN; ESTROGEN RECEPTOR; HEMATOXYLIN; ISOSULFAN BLUE; METHYLENE BLUE; PROGESTERONE RECEPTOR; TECHNETIUM SULFUR COLLOID TC 99M;

ARTICLE; AXILLARY LYMPH NODE; BREAST CANCER; CANCER RADIOTHERAPY; CANCER RECURRENCE; DIAGNOSTIC ACCURACY; FALSE NEGATIVE RESULT; HUMAN; IMMUNOHISTOCHEMISTRY; INTRAOPERATIVE PERIOD; LYMPH NODE DISSECTION; LYMPH NODE METASTASIS; MASTECTOMY; PARTIAL MASTECTOMY; PRIORITY JOURNAL; RECURRENCE RISK; SENTINEL LYMPH NODE; SENTINEL LYMPH NODE BIOPSY; TREATMENT OUTCOME; TUMOR VOLUME;

ADULT; AGED; AXILLA; BREAST NEOPLASMS; COHORT STUDIES; DISEASE-FREE SURVIVAL; FALSE NEGATIVE REACTIONS; FEMALE; HUMANS; IMMUNOHISTOCHEMISTRY; INCIDENCE; INTRAOPERATIVE CARE; LYMPH NODE EXCISION; LYMPH NODES; MASTECTOMY; MIDDLE AGED; NEOPLASM INVASIVENESS; NEOPLASM RECURRENCE, LOCAL; NEOPLASM STAGING; PROBABILITY; PROSPECTIVE STUDIES; RISK ASSESSMENT; SENSITIVITY AND SPECIFICITY; SENTINEL LYMPH NODE BIOPSY; SURVIVAL ANALYSIS;

EID: 77951929547     PISSN: 00029610     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.amjsurg.2010.01.009     Document Type: Article

References (11)

1. NCCN practice guidelines in oncology. v.2.2006. Breast cancer. http://www.nccn.org/professionals/physician_gls/PDF/breast.pdf Accessed: October 13, 2009
2. Pugliese M.S., Beatty J.D., Tickman R.J., et al. Impact and outcomes of routine microstaging of sentinel lymph nodes in breast cancer: significance of the pN0(i+) and pN1mi categories. Ann Surg Oncol 16 (2009) 113-120
3. Rubio I.T., Korourian S., Cowan C., et al. Use of touch preps for intraoperative diagnosis of sentinel lymph node metastases in breast cancer. Ann Surg Oncol 5 (1998) 689-694
4. Veronesi U., Paganelli G.T., Galimberti V., et al. Sentinel-node biopsy to avoid axillary dissection in breast cancer with clinically negative lymph-nodes. Lancet 349 (1997) 1864-1867
5. Henry-Tillman R.S., Korourian S., Rubio I.T., et al. Intraoperative touch preparation for sentinel lymph node biopsy: a 4-year experience. Ann Surg Oncol 9 (2002) 333-339
6. Al-Shibli K.I., Mohammed H.A., and Mikalsen K.S. Sentinel lymph nodes and breast carcinoma: analysis of 70 cases by frozen section. Ann Saudi Med 25 (2005) 111-114
7. Pugliese M.S., Tickman R., Wang N.P., et al. The utility of intraoperative evaluation of sentinel lymph nodes in breast cancer. Ann Surg Oncol 14 (2007) 1024-1030
8. Martin R.C., Chagpar A., Scoggins C.R., et al. Clinicopathologic factors associated with false-negative sentinel lymph-node biopsy in breast cancer. Ann Surg 241 (2005) 1005-1012
9. Takei H., Kurosumi M., Yoshida T., et al. Axillary lymph node dissection can be avoided in women with breast cancer with intraoperative, false-negative sentinel lymph node biopsies. Breast Cancer 17 (2010) 9-16
10. van Wely B.J., Smidt M.L., de Kievit I.M., et al. False-negative sentinel lymph node biopsy. Br J Surg 95 (2008) 1352-1355
11. Sanli I., Lemaire B.M., Muller A.J., et al. Axillary recurrence after negative sentinel lymph node biopsy: frequency and factors influencing recurrence on the long term. Breast J 15 (2009) 236-241